Showing results (161-170 of 308) with videos related to
Sort By:
Pageof 31
Cancer Treatment Reviews|December 7, 2010
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic targetF De Vita, F Giuliani, N Silvestris, et al.Journal of Biological Regulators and Homeostatic Agents|November 20, 2012
Update of adjustable fortification regimen for preterm infants: a new protocolS Arslanoglu, E Bertino, A Coscia, et al.Brain Research|May 28, 1986
Enhancement of glutamate release in the rat striatum following electrical stimulation of the nigrothalamic pathwayJ A Girault, U Spampinato, M Desban, et al.Clinical Genetics|June 1, 1992
One hundred requests for predictive testing for Huntington's diseaseS A Simpson, J Besson, D Alexander, et al.Brain Research|December 6, 1991
The quaking mouse: an epileptic mutant with alterations affecting the modulatory mechanisms of the NMDA receptor complexN Mitrovic, J Caboche, J B Carré, et al.Journal of Neuroscience Research|December 26, 2001
Regulation of striatal neuropeptide mRNAs: effects of the 5-HT(2) antagonist SR46349B in adult rats with a neonatal 6-hydroxydopamine lesionC Durand, A M Mathieu-Kia, M-J Besson, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1977
Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the ratM F Giorguieff, M L Le Floc'h, J Glowinski, et al.Neurology|July 20, 2007
Experimental models of neuroprotection relevant to multiple sclerosisV W Yong, F Giuliani, M Xue, et al.The European Journal of Neuroscience|September 13, 2001
Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmissionE Valjent, C Pagès, M Rogard, et al.Brain Research|November 29, 1986
Characterization and autoradiographic distribution of vasoactive intestinal peptide binding sites in the rat central nervous systemJ Besson, A Sarrieau, M Vial, et al.Pageof 31